Please login to the form below

Not currently logged in
Email:
Password:

Donald Trump

This page shows the latest Donald Trump news and features for those working in and with pharma, biotech and healthcare.

Trump presses on with reference pricing plan for medicines

Trump presses on with reference pricing plan for medicines

Proposed pilot programme to run until 2025. President Donald Trump says he is working on an executive order that will peg the price the US is prepared to pay for medicines ... Trump says he will publish the order “very shortly”, but for now what is

Latest news

  • Trump backtracks on ‘NHS on the table’ comments Trump backtracks on ‘NHS on the table’ comments

    to the NHS – President Donald Trump abruptly reversed his stance. ... Fast forward a few hours, and Trump backtracked on his earlier position when challenged in an interview with Piers Morgan on ITV’s Good Morning Britain programme.

  • Hancock says “NHS not for sale” in post-Brexit US trade talks Hancock says “NHS not for sale” in post-Brexit US trade talks

    Tensions rise as President Trump arrives for state visit. Freer access to the NHS will be part of any post-Brexit US-UK trade deal, according to US Ambassador Woody Johnson. ... Our NHS is indeed up for sale under the Conservatives.”. Johnson’s

  • Trump’s Brexit trade plan is bad for NHS, say campaigners Trump’s Brexit trade plan is bad for NHS, say campaigners

    MP Jo Stevens (pictured below), who is a leading supporter of the campaign, said in a statement that “Donald Trump’s administration has now made it clear just what it will ... The approach seems somewhat at odds with Trump’s own plan to reform drug

  • Novartis back in the spotlight over Trump/Cohen links Novartis back in the spotlight over Trump/Cohen links

    President Trump’s former lawyer Michael Cohen has explained why Novartis paid him $1.2m to act as a consultant on the Trump administration, to the embarrassment of the drugmaker. ... Pressed by lawmakers, Cohen said that Novartis wanted him to help

  • Novartis aims for 10 blockbuster launches by 2020 Novartis aims for 10 blockbuster launches by 2020

    2018 was an eventful year for the company: Vas Narasimhan started work as the company's CEO in February last year, only to face a scandal around secret payments to Donald ... Trump's lawyer Michael Cohen.

More from news
Approximately 5 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • The rise of CEO activism The rise of CEO activism

    In 2018, Merck CEO Kenneth Frazier famously resigned from Donald Trump’s business advisory council after Trump failed to condemn neo-Nazi protests in Charlottesville. ... Frazier took to Twitter to make his stand and, within an hour, Trump responded by

  • Pharmaceutical social media after Cambridge Analytica Pharmaceutical social media after Cambridge Analytica

    and Donald Trump’s election campaign, or Christopher Wylie, the ‘whistleblower’ and data scientist whose idea at the age of 24 had led to the foundation of Cambridge Analytica. ... Evidence presented to the House of Commons Committee showed that

  • Pharma deals continue to slide Pharma deals continue to slide

    Little did US electors know what would be the effect on the US biopharma industry and its deals when they elected Donald Trump. ... Similarly, the Euro is now around 10% stronger against the dollar since President Trump was inaugurated.

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    Furthermore, while some politicians, including Donald Trump and Theresa May, insist that the UK will be able to offset any loss of EU membership by signing trade deals, experts have warned

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    The reason for the decline in the number of deals in 2016 is not known - Brexit and the election of Donald Trump are unlikely to have had any substantial effect because ... But what of 2017? The analysts expect digital health to be a major investment

More from intelligence
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics